Roche Puts Hold on Tamiflu in United States - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Roche Puts Hold on Tamiflu in United States


ePT--the Electronic Newsletter of Pharmaceutical Technology

Roche Puts Hold on Tamiflu in United States

Roche (Basel, Switzerland, www.roche.com) has put a temporary halt on distribution of the influenza vaccine "Tamiflu" to the United Sates in an effort to deter companies from stockpiling the vaccine for employee use, according to an article in the Oct. 27 edition of The New York Times.

According to the report, the hoarding is a reaction to the recent avian flu pandemic, which has killed more than 60 people in Asia, but has not threatened the United States. Roche representatives stated that there are currently sufficient allotments of the vaccine in the United States and additional quantities will be released as the need arises. However, wholesalers were advised to limit the amount of drug distributed to pharmacies to “preserve their inventory until the beginning of flu season.”

Roche has also suspended shipments to Canada and limited supplies to Germany and Switzerland, according to The Times.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
8%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here